Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Sarah Faubel

Concepts (435)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Kidney Injury
82
2023
638
16.500
Why?
Interleukin-6
17
2023
676
2.980
Why?
Kidney
22
2023
1186
2.660
Why?
Reperfusion Injury
8
2023
254
2.520
Why?
Ischemia
11
2021
363
2.490
Why?
Acute Lung Injury
6
2021
300
2.110
Why?
Lung Injury
6
2017
198
1.980
Why?
Cardiac Surgical Procedures
10
2020
413
1.850
Why?
Renal Replacement Therapy
10
2023
66
1.730
Why?
Water-Electrolyte Imbalance
5
2020
26
1.600
Why?
Nephrectomy
7
2021
150
1.560
Why?
Mice, Inbred C57BL
34
2023
4718
1.560
Why?
Cardio-Renal Syndrome
2
2023
10
1.520
Why?
Sepsis
9
2020
509
1.520
Why?
Cytokines
14
2021
1843
1.320
Why?
Interleukin-10
6
2017
297
1.290
Why?
Creatinine
11
2020
425
1.200
Why?
Pneumonia
4
2021
568
1.150
Why?
Postoperative Complications
9
2020
2150
1.110
Why?
Mice
44
2023
14928
1.030
Why?
Biomarkers
18
2023
3419
1.010
Why?
Caspase 1
11
2014
140
1.010
Why?
Interleukin-18
10
2019
219
1.000
Why?
Oxidative Stress
2
2021
1085
0.910
Why?
Metabolome
3
2021
285
0.900
Why?
Lipocalins
3
2019
35
0.900
Why?
Azotemia
1
2023
6
0.890
Why?
Lipocalin-2
7
2023
62
0.870
Why?
Disease Models, Animal
16
2023
3545
0.830
Why?
Body Fluids
2
2020
58
0.820
Why?
Animals
54
2023
31868
0.810
Why?
Cardiopulmonary Bypass
3
2019
176
0.800
Why?
Intensive Care Units
8
2021
620
0.790
Why?
Tissue Inhibitor of Metalloproteinase-2
4
2019
12
0.790
Why?
Kidney Function Tests
2
2019
141
0.750
Why?
Insulin-Like Growth Factor Binding Proteins
3
2018
24
0.740
Why?
Nephrologists
2
2017
12
0.730
Why?
Hospital Mortality
9
2020
777
0.730
Why?
Cisplatin
7
2016
262
0.710
Why?
Urokinase-Type Plasminogen Activator
1
2020
28
0.710
Why?
Critical Illness
9
2023
645
0.710
Why?
Heart Diseases
2
2023
330
0.700
Why?
Peritoneal Dialysis
2
2018
83
0.660
Why?
Systemic Inflammatory Response Syndrome
2
2017
71
0.660
Why?
Renal Dialysis
6
2021
369
0.660
Why?
Adenosine Triphosphate
2
2021
431
0.650
Why?
Heart Failure, Diastolic
1
2019
20
0.640
Why?
Pulmonary Edema
1
2019
116
0.620
Why?
Kidney Diseases
5
2021
350
0.620
Why?
Chemokine CXCL1
6
2012
66
0.600
Why?
Lung
7
2023
3595
0.590
Why?
Male
53
2023
55737
0.580
Why?
Glomerular Filtration Rate
6
2023
604
0.580
Why?
Humans
67
2023
115052
0.570
Why?
CD4-Positive T-Lymphocytes
3
2017
965
0.560
Why?
Critical Care
4
2021
476
0.550
Why?
Interleukin-1beta
6
2014
370
0.550
Why?
Nephrology
3
2016
48
0.550
Why?
Proteinuria
3
2019
77
0.530
Why?
Peroxidase
6
2017
157
0.530
Why?
Spectroscopy, Near-Infrared
1
2016
47
0.530
Why?
Hyperkalemia
1
2016
26
0.520
Why?
Kidney Tubular Necrosis, Acute
4
2015
22
0.520
Why?
Models, Animal
1
2017
348
0.500
Why?
Containment of Biohazards
1
2015
11
0.500
Why?
Acidosis
1
2016
87
0.490
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2015
21
0.490
Why?
Hemorrhagic Fever, Ebola
1
2015
33
0.480
Why?
Losartan
1
2014
9
0.480
Why?
Caspase Inhibitors
6
2014
78
0.480
Why?
Lisinopril
1
2014
14
0.480
Why?
Respiration, Artificial
4
2018
526
0.480
Why?
Neutrophil Infiltration
4
2012
94
0.470
Why?
Angiotensin II Type 1 Receptor Blockers
1
2014
29
0.470
Why?
Chlorides
3
2020
127
0.460
Why?
Thrombocytopenia
3
2021
178
0.450
Why?
Tumor Necrosis Factor-alpha
4
2013
1138
0.450
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2014
180
0.440
Why?
Early Medical Intervention
1
2013
51
0.430
Why?
Ultrasonography, Doppler
1
2013
105
0.430
Why?
Severity of Illness Index
5
2014
2551
0.430
Why?
Apoptosis
10
2019
2366
0.410
Why?
Interleukin-8
2
2013
238
0.410
Why?
Developing Countries
1
2013
236
0.400
Why?
Acute-Phase Proteins
3
2019
64
0.390
Why?
Energy Metabolism
3
2021
729
0.380
Why?
Diagnostic Imaging
1
2014
290
0.380
Why?
Kidney Tubules, Proximal
2
2014
113
0.380
Why?
Splenectomy
1
2011
53
0.380
Why?
Kidney Failure, Chronic
4
2019
489
0.360
Why?
Antibodies, Monoclonal
2
2013
1268
0.330
Why?
Hepatocytes
2
2020
196
0.320
Why?
Multiple Organ Failure
1
2009
142
0.320
Why?
Macrophages, Alveolar
1
2011
351
0.310
Why?
Uremia
1
2008
14
0.310
Why?
Antineoplastic Agents
5
2016
1879
0.310
Why?
Randomized Controlled Trials as Topic
2
2019
1215
0.300
Why?
Mice, Knockout
9
2021
2585
0.300
Why?
Time Factors
8
2019
6142
0.290
Why?
Endothelial Cells
6
2019
685
0.290
Why?
Inflammation Mediators
5
2021
476
0.290
Why?
Inflammation
5
2019
2485
0.280
Why?
Endotoxins
3
2013
205
0.270
Why?
Female
28
2022
59619
0.260
Why?
Prospective Studies
5
2023
6232
0.260
Why?
Respiratory Insufficiency
2
2011
290
0.260
Why?
Blood Urea Nitrogen
4
2013
51
0.260
Why?
Delayed Graft Function
1
2005
26
0.250
Why?
Necrosis
4
2014
210
0.250
Why?
Risk Factors
12
2021
8642
0.250
Why?
Lymphocyte Depletion
1
2005
116
0.250
Why?
Lung Diseases
2
2009
703
0.250
Why?
Macrophages
6
2021
1267
0.250
Why?
Clinical Trials as Topic
4
2016
937
0.240
Why?
Infant, Newborn
7
2023
5040
0.240
Why?
Caspases
7
2013
245
0.240
Why?
Autophagy
2
2021
234
0.240
Why?
Heart Failure
2
2019
1962
0.240
Why?
Intensive Care Units, Pediatric
4
2020
147
0.230
Why?
Predictive Value of Tests
3
2014
1812
0.230
Why?
Retrospective Studies
13
2023
12548
0.230
Why?
Hepcidins
1
2023
21
0.220
Why?
Infant
6
2018
7946
0.220
Why?
Acute-Phase Reaction
1
2023
39
0.220
Why?
Furosemide
1
2023
32
0.220
Why?
Cell Membrane
1
2007
681
0.220
Why?
Caspase 3
8
2011
237
0.220
Why?
Child, Preschool
7
2020
9093
0.210
Why?
Spleen
2
2017
486
0.210
Why?
Capillary Leak Syndrome
2
2012
13
0.200
Why?
Arachidonate 12-Lipoxygenase
1
2021
13
0.200
Why?
Arachidonate 15-Lipoxygenase
1
2021
16
0.200
Why?
Nephritis
1
2021
20
0.200
Why?
Propensity Score
2
2019
224
0.190
Why?
Ureteral Obstruction
1
2021
54
0.190
Why?
Drug Delivery Systems
3
2016
296
0.190
Why?
Autophagy-Related Proteins
1
2021
39
0.180
Why?
Kidney Tubules
3
2012
107
0.180
Why?
Liver
2
2023
1681
0.180
Why?
Receptors, Urokinase Plasminogen Activator
1
2020
10
0.180
Why?
Fibrosis
3
2021
454
0.180
Why?
Diagnosis, Differential
2
2015
1355
0.170
Why?
Chemokine CX3CL1
3
2011
21
0.170
Why?
Sex Factors
3
2022
1721
0.170
Why?
Dialysis Solutions
1
2019
21
0.170
Why?
Kidney Transplantation
1
2005
549
0.170
Why?
Renal Insufficiency, Chronic
2
2015
486
0.160
Why?
Biopsy, Needle
1
2019
183
0.160
Why?
Bronchopulmonary Dysplasia
1
2023
330
0.160
Why?
Feasibility Studies
3
2017
747
0.160
Why?
Norwood Procedures
1
2018
22
0.160
Why?
Random Allocation
1
2019
336
0.150
Why?
Practice Guidelines as Topic
2
2016
1399
0.150
Why?
Amino Acid Chloromethyl Ketones
3
2014
22
0.150
Why?
Delivery of Health Care
2
2015
835
0.150
Why?
Length of Stay
5
2020
951
0.150
Why?
Milrinone
1
2018
24
0.150
Why?
Recovery of Function
2
2019
575
0.150
Why?
History, 20th Century
1
2019
267
0.150
Why?
Metabolomics
2
2021
527
0.150
Why?
Prognosis
3
2014
3335
0.150
Why?
Hypoplastic Left Heart Syndrome
1
2018
110
0.140
Why?
Cell Line
5
2021
2645
0.140
Why?
Immunohistochemistry
3
2019
1634
0.140
Why?
Hyaluronic Acid
2
2016
189
0.140
Why?
Survival Rate
4
2018
1646
0.140
Why?
Postoperative Care
1
2018
222
0.140
Why?
Cell Cycle Checkpoints
1
2017
84
0.140
Why?
Blood Pressure
2
2022
1539
0.140
Why?
Disease Progression
4
2019
2389
0.140
Why?
Middle Aged
13
2021
26831
0.140
Why?
CD4 Antigens
1
2017
124
0.140
Why?
Mice, Mutant Strains
3
2005
272
0.130
Why?
Drug-Related Side Effects and Adverse Reactions
1
2019
242
0.130
Why?
Echocardiography
1
2019
557
0.130
Why?
Endotoxemia
2
2008
82
0.130
Why?
Hemodialysis Units, Hospital
1
2015
5
0.130
Why?
Risk Assessment
4
2019
2976
0.130
Why?
Quinolines
2
2014
129
0.130
Why?
Heart
1
2019
610
0.120
Why?
Patient Isolation
1
2015
18
0.120
Why?
Developed Countries
1
2015
28
0.120
Why?
Contraindications
1
2015
86
0.120
Why?
Transforming Growth Factor beta
2
2015
448
0.120
Why?
Africa
1
2015
95
0.120
Why?
Ebolavirus
1
2015
34
0.120
Why?
Equipment Contamination
1
2015
54
0.120
Why?
Mice, Transgenic
5
2011
1955
0.120
Why?
Quality Improvement
2
2019
953
0.120
Why?
Interleukin-1alpha
1
2014
55
0.120
Why?
Delayed-Action Preparations
1
2015
159
0.120
Why?
Cardiovascular Diseases
2
2019
1729
0.120
Why?
Nitric Oxide
3
2008
827
0.110
Why?
Anticoagulants
2
2015
546
0.110
Why?
Travel
1
2015
121
0.110
Why?
Up-Regulation
1
2017
812
0.110
Why?
Myocardium
1
2019
922
0.110
Why?
Kinetics
1
2017
1558
0.110
Why?
Calpain
4
2006
53
0.110
Why?
Oncogene Proteins
1
2013
53
0.110
Why?
Bronchoalveolar Lavage Fluid
2
2013
590
0.110
Why?
Adolescent
7
2020
17866
0.110
Why?
Workload
1
2014
132
0.110
Why?
Age Factors
3
2018
2894
0.110
Why?
Interleukins
2
2011
236
0.110
Why?
Inflammatory Bowel Diseases
1
2017
288
0.100
Why?
Child
7
2020
18409
0.100
Why?
Receptors, Interleukin-8B
1
2012
23
0.100
Why?
Albumins
1
2013
89
0.100
Why?
Enzyme-Linked Immunosorbent Assay
3
2011
797
0.100
Why?
Podocytes
1
2013
44
0.100
Why?
Hydrogels
2
2016
575
0.100
Why?
Antibodies
2
2012
372
0.100
Why?
Disease Outbreaks
1
2015
309
0.100
Why?
Endocytosis
1
2013
151
0.100
Why?
B-Lymphocytes
1
2017
772
0.100
Why?
Flow Cytometry
3
2011
1084
0.100
Why?
Ambulatory Care
1
2015
478
0.100
Why?
Toll-Like Receptor 2
1
2012
109
0.100
Why?
Cold Temperature
3
2011
129
0.100
Why?
Drug Therapy, Combination
1
2014
955
0.100
Why?
Anti-Inflammatory Agents
1
2015
451
0.100
Why?
Complement Factor B
1
2012
100
0.100
Why?
Heart Defects, Congenital
1
2018
665
0.100
Why?
Trachea
1
2013
234
0.090
Why?
Radiography
1
2014
827
0.090
Why?
MicroRNAs
1
2017
603
0.090
Why?
Organ Preservation
1
2011
67
0.090
Why?
Caspase 8
3
2005
43
0.090
Why?
Nitric Oxide Synthase Type II
2
2008
157
0.090
Why?
Patient Selection
4
2019
646
0.090
Why?
Continuity of Patient Care
1
2013
253
0.090
Why?
Chemokines
2
2008
213
0.090
Why?
Ultrasonography
1
2014
636
0.090
Why?
Neutrophils
2
2007
1164
0.090
Why?
Patient Care Team
1
2015
515
0.090
Why?
Analysis of Variance
1
2013
1229
0.090
Why?
Immunoblotting
3
2005
282
0.090
Why?
L-Lactate Dehydrogenase
2
2007
107
0.090
Why?
Bleomycin
1
2011
228
0.090
Why?
Survivors
1
2013
410
0.090
Why?
Research Design
1
2015
930
0.090
Why?
Polycystic Kidney Diseases
2
2007
55
0.080
Why?
Toll-Like Receptor 4
1
2012
286
0.080
Why?
Complement Activation
1
2012
340
0.080
Why?
Aged
8
2021
19122
0.080
Why?
Proto-Oncogene Proteins
1
2013
609
0.080
Why?
Monocytes
1
2011
503
0.080
Why?
Hepatitis A Virus Cellular Receptor 1
2
2019
35
0.080
Why?
NF-kappa B
2
2013
637
0.080
Why?
Dendritic Cells
1
2012
436
0.080
Why?
Macrophages, Peritoneal
1
2009
91
0.080
Why?
Fluid Therapy
1
2009
122
0.080
Why?
Pulmonary Fibrosis
1
2011
323
0.080
Why?
CD11b Antigen
4
2009
58
0.080
Why?
Case-Control Studies
2
2019
3015
0.080
Why?
Mass Screening
1
2015
1012
0.080
Why?
Caspase 9
2
2004
48
0.080
Why?
Capillary Permeability
1
2008
135
0.070
Why?
Receptors, Chemokine
1
2007
43
0.070
Why?
Urothelium
1
2008
33
0.070
Why?
RNA, Messenger
4
2009
2563
0.070
Why?
Endpoint Determination
3
2012
69
0.070
Why?
Water-Electrolyte Balance
2
2018
26
0.070
Why?
Receptors, Vascular Endothelial Growth Factor
1
2007
103
0.070
Why?
Databases, Factual
1
2011
1132
0.070
Why?
Adult
7
2021
30658
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2008
349
0.070
Why?
Phosphatidylinositol 3-Kinases
1
2008
331
0.070
Why?
Treatment Outcome
2
2019
9123
0.070
Why?
Proto-Oncogene Proteins c-akt
1
2008
400
0.070
Why?
Cell Hypoxia
1
2007
220
0.070
Why?
Genes, T-Cell Receptor alpha
1
2005
11
0.060
Why?
Enzyme Inhibitors
2
2008
752
0.060
Why?
Pilot Projects
3
2018
1375
0.060
Why?
Liver Transplantation
1
2013
774
0.060
Why?
Albuminuria
2
2019
164
0.060
Why?
Survival Analysis
2
2019
1211
0.060
Why?
Insulin Resistance
1
2013
1077
0.060
Why?
Odds Ratio
2
2018
957
0.060
Why?
Polycystic Kidney, Autosomal Dominant
2
2005
209
0.060
Why?
Young Adult
3
2017
10498
0.060
Why?
Cysteine Proteinase Inhibitors
1
2004
45
0.060
Why?
Rats
4
2023
4973
0.060
Why?
Tomography, X-Ray Computed
1
2013
2341
0.060
Why?
Cytosol
1
2004
208
0.060
Why?
Myocardial Ischemia
1
2005
236
0.060
Why?
Colorado
3
2019
4089
0.050
Why?
Cell Proliferation
2
2007
2191
0.050
Why?
Contrast Media
2
2016
369
0.050
Why?
Magnetic Resonance Imaging
1
2014
3118
0.050
Why?
United States
3
2015
12227
0.050
Why?
Gene Expression Regulation
2
2013
2329
0.050
Why?
Brain Ischemia
1
2005
297
0.050
Why?
Comorbidity
2
2019
1457
0.050
Why?
Lipoxygenase Inhibitors
1
2021
36
0.050
Why?
Sample Size
2
2012
112
0.050
Why?
Kidney Glomerulus
2
2013
100
0.050
Why?
Stroke
2
2019
1015
0.050
Why?
Cellular Microenvironment
1
2021
78
0.050
Why?
Cells, Cultured
4
2012
3896
0.050
Why?
Statistics as Topic
2
2012
298
0.050
Why?
Platelet Count
1
2021
83
0.050
Why?
Animals, Newborn
1
2023
778
0.050
Why?
Mechanistic Target of Rapamycin Complex 2
1
2021
55
0.050
Why?
Mice, Inbred BALB C
2
2015
1153
0.050
Why?
Obesity
1
2013
2524
0.050
Why?
Mechanistic Target of Rapamycin Complex 1
1
2021
95
0.040
Why?
Lysosomes
1
2021
123
0.040
Why?
Vascular Endothelial Growth Factor A
1
2023
499
0.040
Why?
Leukocytes
1
2021
277
0.040
Why?
Extracellular Signal-Regulated MAP Kinases
1
2021
157
0.040
Why?
Bicarbonates
1
2020
41
0.040
Why?
Incidence
2
2018
2318
0.040
Why?
Matched-Pair Analysis
1
2019
33
0.040
Why?
Netrin-1
1
2019
11
0.040
Why?
Trefoil Factor-3
1
2019
5
0.040
Why?
Clusterin
1
2019
10
0.040
Why?
beta 2-Microglobulin
1
2019
45
0.040
Why?
Hospitals, University
1
2019
170
0.040
Why?
Cystatin C
1
2019
62
0.040
Why?
Hospitalization
2
2018
1755
0.040
Why?
Signal Transduction
3
2021
4525
0.040
Why?
Fatty Acid-Binding Proteins
1
2019
61
0.040
Why?
Age Distribution
1
2019
340
0.040
Why?
Sex Distribution
1
2019
335
0.040
Why?
Substance Abuse, Intravenous
1
2019
99
0.040
Why?
Zebrafish
1
2022
411
0.040
Why?
Multicenter Studies as Topic
1
2019
250
0.040
Why?
Models, Theoretical
1
2022
517
0.040
Why?
Exosomes
1
2019
91
0.040
Why?
Drug Administration Schedule
1
2019
719
0.040
Why?
Cardiotonic Agents
1
2018
119
0.040
Why?
Thoracic Surgery
1
2018
105
0.030
Why?
Immunocompromised Host
1
2018
196
0.030
Why?
Decision Trees
1
2016
81
0.030
Why?
Colitis, Ulcerative
1
2017
105
0.030
Why?
Heterozygote
2
2007
251
0.030
Why?
Sodium Bicarbonate
1
2015
40
0.030
Why?
Free Radical Scavengers
1
2015
78
0.030
Why?
Caspase 2
2
2006
14
0.030
Why?
Cohort Studies
2
2018
4904
0.030
Why?
Erythropoietin
1
2015
72
0.030
Why?
Early Diagnosis
1
2016
218
0.030
Why?
Reimbursement Mechanisms
1
2015
77
0.030
Why?
In Situ Nick-End Labeling
2
2005
119
0.030
Why?
Acetylcysteine
1
2015
142
0.030
Why?
Methicillin-Resistant Staphylococcus aureus
1
2017
191
0.030
Why?
Protective Agents
1
2014
38
0.030
Why?
Interprofessional Relations
1
2016
251
0.030
Why?
Interleukin-1
2
2012
970
0.030
Why?
Antioxidants
2
2008
530
0.030
Why?
Aged, 80 and over
2
2017
6357
0.030
Why?
Phenotype
1
2021
2815
0.030
Why?
Lipopolysaccharides
1
2017
817
0.030
Why?
Crohn Disease
1
2017
196
0.030
Why?
Smoking
1
2019
1392
0.030
Why?
Health Policy
1
2015
334
0.030
Why?
Clodronic Acid
1
2012
8
0.030
Why?
Cost of Illness
1
2014
254
0.030
Why?
Global Health
1
2014
288
0.020
Why?
Diphtheria Toxin
1
2012
51
0.020
Why?
Diet, High-Fat
1
2013
225
0.020
Why?
Chemokine CCL2
1
2012
105
0.020
Why?
Diabetes Mellitus
1
2019
906
0.020
Why?
Lung Compliance
1
2011
49
0.020
Why?
Interleukin-33
1
2011
38
0.020
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
140
0.020
Why?
Immunotherapy
1
2015
474
0.020
Why?
Postoperative Period
1
2012
292
0.020
Why?
Trauma Severity Indices
1
2011
111
0.020
Why?
Informed Consent
1
2012
161
0.020
Why?
Medicare
1
2015
666
0.020
Why?
Guideline Adherence
1
2014
492
0.020
Why?
Algorithms
1
2017
1489
0.020
Why?
Patient Acceptance of Health Care
1
2015
679
0.020
Why?
Collagen
1
2011
416
0.020
Why?
Body Weight
1
2013
873
0.020
Why?
Liver Diseases
1
2011
259
0.020
Why?
Thiocarbamates
1
2008
6
0.020
Why?
Chromones
1
2008
35
0.020
Why?
Sensitivity and Specificity
1
2013
1715
0.020
Why?
Adoptive Transfer
1
2009
198
0.020
Why?
Attitude of Health Personnel
1
2015
976
0.020
Why?
GTP Cyclohydrolase
1
2008
7
0.020
Why?
Amidines
1
2008
16
0.020
Why?
Benzylamines
1
2008
39
0.020
Why?
Cyclic N-Oxides
1
2008
30
0.020
Why?
Proline
1
2008
72
0.020
Why?
CX3C Chemokine Receptor 1
1
2007
18
0.020
Why?
Fluorescent Antibody Technique
1
2009
396
0.020
Why?
Antimycin A
1
2007
13
0.020
Why?
Health Promotion
1
2014
686
0.020
Why?
Renal Circulation
1
2008
53
0.020
Why?
Spin Labels
1
2008
48
0.020
Why?
Cell Count
1
2008
304
0.020
Why?
Morpholines
1
2008
102
0.020
Why?
Antibodies, Anti-Idiotypic
1
2007
54
0.020
Why?
von Willebrand Factor
1
2007
56
0.020
Why?
Rats, Inbred Strains
1
2007
376
0.020
Why?
Sex Characteristics
1
2011
635
0.020
Why?
MAP Kinase Signaling System
1
2008
276
0.020
Why?
RNA, Catalytic
1
2007
182
0.020
Why?
Epithelial Cells
1
2012
956
0.020
Why?
Acrylates
1
2006
45
0.020
Why?
Cysteine Endopeptidases
1
2006
60
0.020
Why?
Killer Cells, Natural
1
2009
383
0.020
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
249
0.020
Why?
Acute Disease
1
2008
915
0.020
Why?
Cathepsin B
1
2005
14
0.020
Why?
Reproducibility of Results
1
2013
2799
0.020
Why?
Apoptosis Regulatory Proteins
1
2006
172
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2005
49
0.020
Why?
Caspase 7
1
2005
22
0.020
Why?
Inhibitory Concentration 50
1
2005
75
0.020
Why?
Cell Survival
1
2008
1022
0.020
Why?
Fas Ligand Protein
1
2005
58
0.020
Why?
Thermosensing
1
2004
10
0.020
Why?
Wounds and Injuries
1
2012
723
0.010
Why?
Kidney Cortex
1
2004
23
0.010
Why?
DNA Fragmentation
1
2004
47
0.010
Why?
Sialoglycoproteins
1
2005
158
0.010
Why?
Microvilli
1
2004
70
0.010
Why?
Animals, Genetically Modified
1
2005
215
0.010
Why?
Mitochondrial Proteins
1
2006
220
0.010
Why?
Perfusion
1
2004
151
0.010
Why?
Cross-Sectional Studies
1
2014
4411
0.010
Why?
Interleukin 1 Receptor Antagonist Protein
1
2005
254
0.010
Why?
Cell Movement
1
2007
866
0.010
Why?
Membrane Glycoproteins
1
2005
429
0.010
Why?
Surveys and Questionnaires
1
2014
4631
0.010
Why?
Rats, Sprague-Dawley
1
2007
2212
0.010
Why?
Carrier Proteins
1
2006
696
0.010
Why?
Temperature
1
2004
578
0.010
Why?
Endothelium, Vascular
1
2007
850
0.010
Why?
Faubel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)